Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis [7]

British Journal of Dermatology

Volumn 145, Issue 4, 2001, Pages 676-678

  Yazawa, N ^a   Ihn, H ^a   Yamane, K ^a   Kubo, M ^a   Fujimoto, M ^a   Kikuchi, K ^a   Soma, Y ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYTOKINE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DERMATOMYOSITIS; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; FEMALE; HUMAN; IMMUNOPHENOTYPING; JUVENILE DIABETES MELLITUS; LABORATORY TEST; LETTER; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MALE; MUSCLE BIOPSY; NEOPLASM; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PRURITUS; SKIN BIOPSY; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD30; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; SOLUBILITY; T-LYMPHOCYTE SUBSETS;

EID: 0035788557     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04417.x     Document Type: Letter

References (16)

1. Bohan A. Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975: 292: 344-7.
2. Mosmann TR. Sand S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996: 17: 138-46.
3. Falini B. Pileri S. Pizzolo G et al. CD30 (Kid) molecule: a new cytokine receptor of the tunor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995: 85: 1-]4.
4. Schwab U. Stein H. Gerdes J et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982: 299: 655-67.
5. Dei Prete G. De Carli M. Almerigogna F et al. Preferential expression of CD30 bv human CD4+ T cells producing Th2 cytokines. FASEB J 1995: 9: 81-6.
6. Romagnani S. Del Prete G. Maggi E et al. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995: 57: 726-30.
7. Gruss HI. Boiani N. Williams DE et al. Pteiotrophic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994: 83: 2145-56.
8. LeRoy EC. Krieg T. Black C. et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988: 15: 202-5.
9. Takehara K. Moroi Y. Nakabayashi Y et al. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983: 26: 612-6.
10. Gerli R. Muscat C. Bistoni O et al. High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol 1995: 102: 547-50.
11. Caligaris-Cappio F. Bertero MT. Converso M et al. Circulating levels of soluble CD30, a marker of ceils producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 1995: 13: 339-43.
12. Giacomelli R. Cipriani R. Lattanzio M et al. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease. Clin Exp Immunol 1997: 1O8: 42-6.
13. Ihn H. Yazawa N. Kubo M et al. Circulating levels of soluble CD30 are increased in patients with localized sclerodernm and correlated with serological and clinical features of the disease. J Rheumatol 2000: 27: 698-702
14. Hagiwara E. Adams FM. Plotz PH et al. Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis. Clin Exp Rheumatol 1996: 14: 485-91.
15. Iannone F. Cauli A. Yanni G et al. T-lymphocyte immunophenotyping in polymvositis and dermatomvositis. Br J Rheumatol 1996: 35: 839-45.
16. Dummer W. Brocker EB. Bastian BC. Elevated serum levels of soluble CD30 are associated with atopic dermatitis. but not with respiratory atopic disorders and allergic contact dermatitis. Br J Dermatol 1997: 117: 185-7.